ACUPUNCTURE: Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer

Sponsor
Wake Forest University Health Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT02589938
Collaborator
(none)
230
36
3
116.5
6.4
0.1

Study Details

Study Description

Brief Summary

This study is being done to find out what effects, good and/or bad, acupuncture has on participants and their xerostomia caused by radiation therapy for the treatment of the cancer.

Condition or Disease Intervention/Treatment Phase
  • Other: Standard Oral Hygiene
  • Other: Standard Oral Hygiene + True Acupuncture
  • Other: Standard Oral Hygiene + Sham Acupuncture
N/A

Detailed Description

Patients who have met all eligibility criteria will be randomized to standard oral hygiene, standard oral hygiene + true acupuncture twice weekly for 4 weeks, or standard oral hygiene + sham acupuncture twice weekly for 4 weeks by a form of adaptive randomization, called minimization, because simple randomization could result in covariate imbalances .

The acupuncture points will be at three sites on each ear (Shenmen, Point Zero, Salivary Gland 2-prime), a site on the chin (CV24), a site on each forearm (Lu7), a site on each hand (LI 1-prime), a site on each leg (K6), and one placebo needle at Gb32 for a total of 14 sites. All sites will be applied for 20 minutes. For body points, standardized techniques for location will be utilized, which are based on anatomical landmarks as well as proportional measurements using the patient's own body. For example, finger breadth is based on each patient's middle finger, and the proportional unit of measure, the "cun," is defined as the distance between the two medial ends of the creases of the interphalangeal joints when the middle finger is flexed. Earpoint locations will mimic standard practice and be identified by the acupuncturists.

Study Design

Study Type:
Interventional
Actual Enrollment :
230 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
Actual Study Start Date :
Nov 11, 2012
Actual Primary Completion Date :
Jul 29, 2022
Actual Study Completion Date :
Jul 29, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard Oral Hygiene

All patients will receive standard oral hygiene patient teaching information that includes instructions regarding mouth rinses, use of lip balms, use of mild fluoride toothpaste, the importance of adequate oral hydration, and other standard advice. Each participating site determines the standard oral hygiene recommendations used at their site.

Other: Standard Oral Hygiene
Oral hygiene care provided per individual institutions standard of care.
Other Names:
  • Oral Hygiene
  • Experimental: Standard Oral Hygiene + True Acupuncture

    All patients will receive standard oral hygiene patient teaching information that includes instructions regarding mouth rinses, use of lip balms, use of mild fluoride toothpaste, the importance of adequate oral hydration, and other standard advice. Each participating site determines the standard oral hygiene recommendations used at their site. The True acupuncture points will be at 3 sites on each ear, a site on the chin, on each forearm, a site on each hand, a site on each leg, and one placebo needle for a total of 14 sites. All sites will be applied for 20 minutes.

    Other: Standard Oral Hygiene + True Acupuncture
    Oral hygiene care provided per individual institutions standard of care. 14 true acupoint sites will be selected and applied to each participant for 20 minutes at each session. There will be 2 sessions a week for 8 weeks.

    Other: Standard Oral Hygiene + Sham Acupuncture

    All patients will receive standard oral hygiene patient teaching information that includes instructions regarding mouth rinses, use of lip balms, use of mild fluoride toothpaste, the importance of adequate oral hydration, and other standard advice. Each participating site determines the standard oral hygiene recommendations used at their site. The Sham acupuncture points will be given according to the same schedule as the active acupuncture points, except the Sham needles will be placed below, above or between true active points.

    Other: Standard Oral Hygiene + Sham Acupuncture
    Oral hygiene care provided per individual institutions standard of care. 14 sham acupoint sites will be selected and applied to each participant for 20 minutes at each session. There will be 2 sessions a week for 8 weeks.
    Other Names:
  • Placebo acupuncture needle
  • Outcome Measures

    Primary Outcome Measures

    1. 9 Item Xerostomia Questionnaire [Baseline to 4 weeks post acupuncture]

      Self reported Xerostomia questionnaire completed prior to study randomization. Each item is scored on a scale of 0-10 with higher scores indicating greater dryness or discomfort due to dryness, yielding a total between 0 and 90.

    Secondary Outcome Measures

    1. Duration of response to a maximum of 6 months [Baseline to 6 Months]

      Duration of response assessed by determining Xerostomia Questionnaire scores at 8 and 12 weeks and the 6 month follow-up.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Must be at least 18 years of age and able to give informed consent.

    • Must be able to read, write and understand English.

    • Must have a diagnosis of head/neck cancer.

    • Must have received bilateral radiation therapy, and subsequently developed grade 2 or 3 xerostomia, according to modified RTOG scale:

    • Grade 0 - None

    • Grade 1 - Slight dryness of mouth (good response on stimulation and no significant dietary alterations necessary)

    • Grade 2 - Moderate dryness of mouth (poor response on stimulation and altered oral intake required such as frequent water, oral lubricants, or soft-moist foods)

    • Grade 3 - Complete dryness of mouth (no response on stimulation and difficult oral alimentation; IV fluids, pureed diet or tube feedings may be required)

    • Grade 4 - Fibrosis

    • Must have received external beam radiation at a mean dose of at least 24 Gy to one of the parotid glands. The other gland can receive less than 24 Gy.

    • Must have completed radiotherapy at least 12 months prior to entry.

    • Must have anatomically intact parotid and submandibular glands. A focused (head/neck) history and exam conducted by a physician or dentist within the past year is required.

    • Must be acupuncture naïve.

    • Must have ECOG performance status of 0-2.

    Exclusion Criteria:
    • History of xerostomia, Sjogren's disease or other illness known to affect salivation prior to head/neck radiation.

    • Suspected or known closure of salivary gland ducts on either side. (Patients addressed in inclusion criteria (i.e. those who have had one submandibular gland removed) are expected to have closure to the removed submandibular gland and will be exempt from this exclusion criteria.)

    • Currently receiving or planning to use drugs, herbs, alternative medicines, or devices that could affect salivary production. Treatment known to affect salivation should be stopped at least 14 days prior to enrollment. Over the counter products used for salivary substitution are allowed, but will need to be discontinued for at least 24 hours prior to saliva and questionnaire data collection.

    • Have received any investigational new drug within the past 30 days or planning to receive such during the study period.

    • Active systemic infection or skin infection at or near the acupuncture sites.

    • Receiving chemotherapy during study period.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank California United States 91505
    2 Kaiser Permanente-San Francisco San Francisco California United States 94115
    3 Kaiser Permanente-Santa Teresa-San Jose San Jose California United States 95119
    4 Kaiser Permanente-San Rafael San Rafael California United States 94903
    5 Kaiser San Rafael-Gallinas San Rafael California United States 94903
    6 Kaiser Permanente Medical Center - Santa Clara Santa Clara California United States 95051
    7 Kaiser Permanente-Santa Rosa Santa Rosa California United States 95403
    8 Kaiser Permanente-South San Francisco South San Francisco California United States 94080
    9 Kaiser Permanente-Walnut Creek Walnut Creek California United States 94596
    10 Queen's Medical Center Honolulu Hawaii United States 96813
    11 University of Hawaii Cancer Center Honolulu Hawaii United States 96813
    12 The Cancer Center of Hawaii-Liliha Honolulu Hawaii United States 96817
    13 John H Stroger Jr Hospital of Cook County Chicago Illinois United States 60612
    14 Physicians' Clinic of Iowa PC Cedar Rapids Iowa United States 52402
    15 Saint Luke's Hospital Cedar Rapids Iowa United States 52402
    16 Mercy Health Saint Mary's Grand Rapids Michigan United States 49503
    17 Spectrum Health at Butterworth Campus Grand Rapids Michigan United States 49503
    18 Mercy Hospital Coon Rapids Minnesota United States 55433
    19 Fairview Southdale Hospital Edina Minnesota United States 55435
    20 Hennepin County Medical Center Minneapolis Minnesota United States 55415
    21 Park Nicollet Clinic - Saint Louis Park Saint Louis Park Minnesota United States 55416
    22 University of New Mexico Cancer Center Albuquerque New Mexico United States 87102
    23 Christus Saint Vincent Regional Cancer Center Santa Fe New Mexico United States 87505
    24 Wake Forest University Health Sciences Winston-Salem North Carolina United States 27157
    25 Adena Regional Medical Center Chillicothe Ohio United States 45601
    26 Columbus Oncology and Hematology Associates Inc Columbus Ohio United States 43214
    27 Providence Portland Medical Center Portland Oregon United States 97213
    28 Prisma Health Cancer Institute - Spartanburg Boiling Springs South Carolina United States 29316
    29 Prisma Health Greenville Memorial Hospital Greenville South Carolina United States 29605
    30 Prisma Health Cancer Institute - Eastside Greenville South Carolina United States 29615
    31 Prisma Health Cancer Institute - Seneca Seneca South Carolina United States 29672
    32 Meharry Medical College Nashville Tennessee United States 37208
    33 MD Anderson in The Woodlands Conroe Texas United States 77384
    34 M D Anderson Cancer Center Houston Texas United States 77030
    35 MD Anderson West Houston Houston Texas United States 77079
    36 Providence Regional Cancer System-Lacey Lacey Washington United States 98503

    Sponsors and Collaborators

    • Wake Forest University Health Sciences

    Investigators

    • Principal Investigator: Suzanne C Danhauer, PhD, Wake Forest University Health Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Wake Forest University Health Sciences
    ClinicalTrials.gov Identifier:
    NCT02589938
    Other Study ID Numbers:
    • IRB00038707
    • REBAWF 97115
    • NCI-2011-02073
    • NCT01141231
    First Posted:
    Oct 28, 2015
    Last Update Posted:
    Aug 1, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Wake Forest University Health Sciences
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 1, 2022